project - Innovative project

Bacterial therapy of infection with enterohaemorrhagic E.coli in a gnotobiotic pig model a
Bacterial therapy of infection with enterohaemorrhagic E.coli in a gnotobiotic pig model a

Currently showing page content in native language where available

Objectives

Human infections with enterohaemorrhagic E. coli can hardly be treated with antibiotics. Research in this project focusses onto an alternative therapeutic approach.

The gnotobiotic piglet model of infection with the German outbreak strain from 2011 O104:H4 will be characterized.

The protective and therapeutic effect of a probiotic E. coli strain producing a recently detected microcin will be tested in a gnotobiotic piglet model during infection with enterohaemorrhagic E. coli.

Objectives

Human infections with enterohaemorrhagic E. coli can hardly be treated with antibiotics. Research in this project focusses onto an alternative therapeutic approach.

The gnotobiotic piglet model of infection with the German outbreak strain from 2011 O104:H4 will be characterized.

The protective and therapeutic effect of a probiotic E. coli strain producing a recently detected microcin will be tested in a gnotobiotic piglet model during infection with enterohaemorrhagic E. coli.

Activities

Human infections with enterohaemorrhagic E. coli can hardly be treated with antibiotics. Research in this project focusses onto an alternative therapeutic approach.

The gnotobiotic piglet model of infection with the German outbreak strain from 2011 O104:H4 will be characterized.

The protective and therapeutic effect of a probiotic E. coli strain producing a recently detected microcin will be tested in a gnotobiotic piglet model during infection with enterohaemorrhagic E. coli.

Activities

Human infections with enterohaemorrhagic E. coli can hardly be treated with antibiotics. Research in this project focusses onto an alternative therapeutic approach.

The gnotobiotic piglet model of infection with the German outbreak strain from 2011 O104:H4 will be characterized.

The protective and therapeutic effect of a probiotic E. coli strain producing a recently detected microcin will be tested in a gnotobiotic piglet model during infection with enterohaemorrhagic E. coli.

Project details
Main funding source
Other rural development funds
Agricultural sectors
Pigs
Currently showing page content in native language where available

Contacts

Project coordinator